What were Crestchem's FY26 numbers?

Revenue of ₹29.61 crore, net profit of ₹2.71 crore, flat year-on-year.

What dividend did the board recommend?

A final dividend of ₹1.50 per share for FY26.

Is the ₹2.25 crore investment in Oleo Biosciences new news?

No, it was previously disclosed as a proposed agenda item; this filing merely formalizes it.

Why is profit flat despite higher revenue?

The company's net profit margin likely decreased, but the filing does not provide a breakdown. The absolute profit remained nearly the same.

Earnings · Chemicals · Micro cap

Crestchem's FY26 revenue rises 18% but profit flat

Net profit nearly unchanged at ₹2.71 cr on revenue of ₹29.61 cr. Board recommends ₹1.50 dividend and formalizes ₹2.25 cr subsidiary investment.

— 1 earlier story on Crestchem Ltd. →

CRSTCHM By Tipsheet Editorial 19 Jun 2026 · 4:35 PM IST Verify on BSE · NSE

Mkt cap₹39.13 cr

P/E14.43×

ROE36.47%

Debt / eq.0.00

₹29.61 cr Revenue, up 18% YoY

What's new

FY26 revenue rose 18% to ₹29.61 crore, but net profit stayed flat at ₹2.71 crore.
Board recommended a final dividend of ₹1.50 per share.
Approved ₹2.25 crore capital commitment in subsidiary Oleo Biosciences, a previously disclosed investment.

Why this matters

For a nano-cap with a market cap of ₹42 crore, profit stagnation despite solid revenue growth is a sign of margin compression. The dividend is modest, and the subsidiary investment was already known, so this filing contains no market-moving news.

What we're watching

Whether margin pressure persists into FY27.
How the ₹2.25 crore investment in Oleo Biosciences contributes to future earnings.
Any update on the utilization of the dividend payout.

The full read

Crestchem's top line grew 18% to ₹29.61 crore for FY26, but net profit barely moved: ₹2.71 crore against ₹2.73 crore the prior year. The board recommended a final dividend of ₹1.50 per share and formally approved a ₹2.25 crore capital commitment in subsidiary Oleo Biosciences. That decision was already disclosed, so no surprise. The investment is material at ≈5.4% of market cap (₹42 crore), but the lack of novelty makes this a routine update. Profit didn't budge despite the revenue jump, a point to watch next year.

Questions answered

What were Crestchem's FY26 numbers?: Revenue of ₹29.61 crore, net profit of ₹2.71 crore, flat year-on-year.
What dividend did the board recommend?: A final dividend of ₹1.50 per share for FY26.
Is the ₹2.25 crore investment in Oleo Biosciences new news?: No, it was previously disclosed as a proposed agenda item; this filing merely formalizes it.
Why is profit flat despite higher revenue?: The company's net profit margin likely decreased, but the filing does not provide a breakdown. The absolute profit remained nearly the same.

Mentioned: Oleo Biosciences

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Crestchem Ltd.

Chemicals

₹39 cr

P/E 14.45×

Latest quarter · Mar 2026

Sales₹10 cr

Net profit₹1 cr

Op. margin+13.7%

EPS₹3.68

Strength & growth

Debt / equity0.00×

Current ratio1.44×

Sales CAGR+82.6%

EPS CAGR+50.8%

Story so far

All notes on CRSTCHM →

19 Jun 2026 · 4:35 PM IST Crestchem's FY26 revenue rises 18% but profit flat
17d ago Crestchem revenue up 18% but profit flat at ₹2.71 cr